We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BCAX market cap is 651.9M. The company's latest EPS is USD -0.9553 and P/E is -12.54.
| Quarter End | Sep 2024 |
|---|---|
| USD (US$) | |
| Total Revenue | 0 |
| Operating Income | -20.63M |
| Net Income | -17.48M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Revenue | 0 |
| Operating Income | -39.89M |
| Net Income | -51.99M |
| Quarter End | Sep 2024 |
|---|---|
| USD (US$) | |
| Total Assets | 524.17M |
| Total Liabilities | 14.62M |
| Total Equity | 509.56M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Assets | 233.98M |
| Total Liabilities | 15.47M |
| Total Equity | -148.77M |
| Market Cap | 651.9M |
| Price to Earnings Ratio | -12.54 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.83 |
| Price to Book Ratio | 2.98 |
| Dividend Yield | - |
| Shares Outstanding | 54.42M |
| Average Volume (1 week) | 298.82k |
| Average Volume (1 Month) | 364.25k |
| 52 Week Change | -54.36% |
| 52 Week High | 28.09 |
| 52 Week Low | 11.43 |
| Spread (Intraday) | 1.3 (10.36%) |
| Company Name | Bicara Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.bicara.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
